Real-world success of de-escalating upadacitinib induction dosing in ulcerative colitis is predicted by steroid-free clinical and biochemical remission, not induction duration.
Journal: Crohn's & colitis 360
•
Abstract
Abstract text is not embedded in this discovery record. Please consult the full-text publication via the source link on the right.
Subjects & Keywords
How to Cite this Article
Dalal RM, Rotondo-Trivette S, Mason AR, et al. (2026). "Real-world success of de-escalating upadacitinib induction dosing in ulcerative colitis is predicted by steroid-free clinical and biochemical remission, not induction duration.". Crohn's & colitis 360. https://doi.org/10.1093/crocol/otag111